Global  

J&J launches final study of COVID-19 vaccine

Video Credit: Reuters - Politics - Duration: 01:09s - Published
J&J launches final study of COVID-19 vaccine

J&J launches final study of COVID-19 vaccine

The drug giant said it would begin a stage three trial of a single-shot vaccine, which could prove easier to administer than rivals that require two inoculations.

This report produced by Zachary Goelman.

Johnson & Johnson on Wednesday (September 23) kicked off a final 60,000-person trial of a single-shot COVID-19 vaccine.

The treatment has the potential to simplify distribution of millions of doses compared with leading rivals requiring two inoculations.

The company said it expects results of the Phase III trial by year end or early next year.

Rival vaccines from Moderna, Pfizer and AstraZeneca all require two shots separated by several weeks, which make them much more difficult to administer.

The race for a vaccine comes amid reports that the U.S. Food and Drug Administration is expected to soon announce more stringent standards for issuing emergency use authorization.

The Washington Post on Tuesday (September 22) reported the FDA is changing its guidance to boost transparency and public trust as health experts grow increasingly concerned the Trump administration might be interfering in the approval process to bolster the president's re-election chances.

According to the Post, vaccine manufacturers will have to follow some trial participants for more than two months after they receive a second shot.

Few vaccine developers were expected to have definitive trial results before the presidential election.

Pfizer Inc had been the exception, although its timetable could slip with the new guidance.




You Might Like


πŸ’‘ One News Page Knowledge: Other News Mentions

Pfizer Pfizer American multinational pharmaceutical corporation

CDC sees virus cases rising, vaccine by year end [Video]

CDC sees virus cases rising, vaccine by year end

The United States is likely to have enough safe and effective COVID-19 vaccines available to inoculate the most vulnerable Americans by the end of 2020, Health and Human Services Secretary Alex Azar said on Wednesday. This report produced by Chris Dignam.

Credit: Reuters - Politics    Duration: 02:21Published

COVID-19 vaccine could be ready by December

Pfizer has released footage of a potential coronavirus vaccine rolling off the production line β€” as the drug giant aims to have 100 million doses ready by the..
WorldNews

Covid 19 coronavirus: Pfizer starts manufacturing vaccine jabs - UK could get 40 million by New Year

Forty million coronavirus vaccines could be heading to the UK in the next two and a half months, it has emerged, after US multinational pharmaceutical..
New Zealand Herald

Pfizer will not seek COVID-19 vaccine authorization before election

Pfizer announced Friday it will apply for FDA emergency use authorization for its COVID-19 vaccine "soon after the safety milestone is achieved in the third week..
CBS News

Thanksgiving would be the earliest that a COVID-19 vaccine may arrive, Pfizer says

An open letter from the frontrunner COVID-19 vaccine producer published Friday ends any expectations a vaccine might be available before Election Day.

USATODAY.com

Johnson & Johnson Johnson & Johnson U.S. multinational medical devices, pharmaceutical and consumer packaged goods manufacturer

Global COVID-19 cases rise by a one-day record [Video]

Global COVID-19 cases rise by a one-day record

Global coronavirus cases rose by more than 400,000 for the first time late on Friday, a record one-day increase as much of Europe enacts new restrictions to curb the outbreak. Freddie Joyner has more.

Credit: Reuters - Politics    Duration: 01:18Published
Johnson & Johnson Halts COVID-19 Vaccine Trial Due to Unexplained Illness [Video]

Johnson & Johnson Halts COVID-19 Vaccine Trial Due to Unexplained Illness

Johnson & Johnson has paused the advanced clinical trial of its experimental COVID-19 vaccine after one of their 60,000 participants became ill.

Credit: Cover Video STUDIO    Duration: 01:19Published

Eli Lilly and Johnson & Johnson have paused COVID-19 vaccine trials. Why experts say that's reassuring, not frightening.

Experts say the recent pause on COVID-19 vaccine and treatment trials aren't unusual, but rather show scientific safety processes are working.

USATODAY.com

Food and Drug Administration Food and Drug Administration Agency of the United States Department of Health and Human Services

FDA approves remdesivir for COVID-19

The antiviral drug reduces recovery time but has not been found to cut the risk of dying from COVID-19.
CBS News

FDA approves remdesivir to treat COVID-19

Photo by Liu Guanguan/China News Service via Getty Images

The Food and Drug Administration approved remdesivir to treat COVID-19 in hospitalized..

The Verge

FDA approves remdesivir for hospitalized COVID-19 patients

The Food and Drug Administration on Thursday approved the antiviral drug remdesivir as a treatment for patients with COVID-19 who require hospitalization.

USATODAY.com

Health secretary denies report he wants to oust FDA head

According to a report published in Politico​, Azar had expressed his frustration with Hahn to several allies within his department
CBS News

HHS Secretary Alex Azar on COVID-19 vaccine timeline and "concerning" pandemic trend

Coronavirus cases are increasing in nearly 75% of the U.S., according to the Centers for Disease Control. Health and Human Services Secretary Alex Azar joined..
CBS News

Coronavirus disease 2019 Coronavirus disease 2019 Infectious respiratory disease caused by severe acute respiratory syndrome coronavirus 2

Live updates: Final presidential debate between Trump and Biden

Debate moderator Kristen Welker plans to bring up COVID-19, families, race, climate change, national security and leadership tonight.
CBS News

Alkmaar lose 13 players to Covid - then win away to Napoli

AZ Alkmaar beat Napoli 1-0 in the Europa League despite missing 13 players because of positive coronavirus tests.
BBC News

Moderna Moderna American biotechnology company

Doctor weighs in on coronavirus vaccine timeline, surge in U.S. cases

Moderna's CEO says interim results are expected next month from a large clinical trial of the company's coronavirus vaccine -- one of several vaccines in the..
CBS News

Pfizer says mid-November is earliest it can seek coronavirus vaccine approval

NEW YORK β€” Pharmaceutical giant Pfizer says that the earliest it can request emergency authorization of its COVID-19 vaccine is the third week of November β€”..
WorldNews
Moderna COVID-19 vaccine appears safe for older adults- study [Video]

Moderna COVID-19 vaccine appears safe for older adults- study

Results from an early safety study of Moderna's coronavirus vaccine candidate in older adults showed that it produced virus-neutralizing antibodies at levels similar to those seen in younger adults, with side effects roughly on par with high-dose flu shots. This report produced by Jillian Kitchener.

Credit: Reuters Studio    Duration: 01:30Published

AstraZeneca British-Swedish pharmaceutical company

Brazilian dies in COVID-19 vaccine trial [Video]

Brazilian dies in COVID-19 vaccine trial

A volunteer who was taking part in clinical trials of the AstraZeneca vaccine in Brazil has died. The Brazilian health authority has confirmed that the trial will continue. Flora Bradley-Watson reports.

Credit: Reuters Studio    Duration: 01:27Published

Covid 19 coronavirus AstraZeneca vaccine: Volunteer dies during human trials

A volunteer taking part in the trial for AstraZeneca's Covid-19 vaccine, which Australians could be given doses of, has died. A volunteer taking part in human..
New Zealand Herald

Volunteer in Oxford-AstraZeneca coronavirus vaccine test dies in Brazil

A volunteer taking part in clinical trials of the Covid-19 vaccine...
WorldNews

US trial of AstraZeneca Covid vaccine may resume this week - Report

AstraZeneca Plc's COVID-19 vaccine trial in the United States is expected to resume as early as this week after the U.S. Food and Drug Administration completed..
WorldNews

Related news from verified sources

Late-stage study of first single-shot vaccine begins in US

Johnson & Johnson is beginning a huge final study to try to prove if a single-dose COVID-19 vaccine...
SeattlePI.com - Published Also reported by •NewsmaxNewsdayDenver PostIndiaTimes


Johnson & Johnson begins final-stage testing on single-dose COVID-19 vaccine

Johnson & Johnson begins final-stage testing on single-dose COVID-19 vaccine Johnson & Johnson is beginning a huge final study to try to prove if a single-dose COVID-19 vaccine...
WorldNews - Published Also reported by •CBC.ca


Coronavirus vaccine study enters final stage in US

Johnson & Johnson is beginning a huge final study to try to prove if a single-dose Covid-19 vaccine...
Belfast Telegraph - Published Also reported by •Denver Post



Tweets about this